Disease Markers / 2016 / Article / Tab 1

Research Article

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients

Table 1

Demographic and clinical characteristics of healthy controls and OND and RRMS patients.

Healthy controls ()OND ()MS ()

Age37.0 ± 7.5; 35.5 (30.3–44.0)42.4 ± 13.7; 41.5 (33.0–49.0)39.2 ± 10.9; 37.0 (30.5–48.0)
Sex: female/male24/1657/3553/36
Disease duration (yrs)5.9 ± 7.1; 3 (1–7.7)
EDSS3.8 ± 1.9; 3.5 (2.5–4.4)
Clinically active MS: /total (%)32/40 (80%)
Clinically stable MS: /total (%)8/40 (20%)

EDSS: expanded disability status scale; MS: multiple sclerosis; RRMS: relapsing-remitting multiple sclerosis; OND: other neurological disorders.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.